Progyny signals $200M share repurchase and targets $1.278B 2025 revenue while expanding supplemental fertility plans (NASDAQ:PGNY)
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...